Product
PRODUCT-
Building 21, Disheng North Street, Beijing Economic and Technological Development Zone, Beijing
-
+86-10-67806114
-
Mr Guo13810071004
Mr Feng13801186597 -
+86-10-67806115
-
[email protected]
Blood System Diseases
time：2020-03-02 
browse：1013second
project name | Indication | Registration classification and dosage form specifications |
CANGRELOR Kan Ge Rui Luo | Anti-platelet aggregation (for postoperative use) to reduce thrombotic cardiovascular events in adult patients with coronary artery disease | 3 + 3 Lyophilized powder injection 50MG |
TICAGRELOR Ti Ge Rui Luo | Used in patients with acute coronary syndromes, including those receiving medication and percutaneous coronary interventions, to reduce the incidence of thrombotic cardiovascular events. | 3 + 4 Tablets 60 / 90MG |
RIVAROXABAN Li Fa Sha Ban | Prevent venous thrombosis after joint replacement. Reduce the risk of stroke in patients with nonvalvular AF. | 3 + 4 Tablet 10/15 / 20MG |
APIXABAN A Pai Sha Ban | For adult patients undergoing elective hip or knee replacement to prevent venous thromboembolism. | 3 + 4 Tablet 2.5 / 5MG |
EDOXABAN | For the prevention of stroke and systemic embolism in adults with nonvalvular atrial fibrillation | 3 + 3 Tablet 15/30 / 60MG |
DEFITELIO Qu Xian Gan Suan | Severe hepatic vein obstruction in adult and pediatric patients undergoing hematopoietic stem cell transplantation | 3 + 3 Lyophilized powder injection 80MG |
POLIDOCANOL Ju Duo Ka Chun | Spider vascular disease (mini varicose veins with a diameter of less than 1MM) and reticulated veins (1 to 3MM in diameter) | 3 + 3 injection 10MG / 2ML, 20MG / 2ML, 180MG / 18ML |
FERRIC CARBOXYMALTOSE Qiang Ji Mai Ya Tang Tie Fu He Wu | Iron deficiency anemia | 3+3注射劑 100MG:2ML/500MG:10ML
|